
FDA Filing Fee Waiver for New Drug Application of NRX-100 for Suicidal Depression
NRx Pharmaceuticals announced the grant of a filing fee waiver by the US Food and Drug Administration (FDA) to exempt NRx from a $4.3 million fee to file its New Drug Application for preservative-free ketamine (NRX-100). NRX-100 is a preservative-free …